ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $163.94bn
- $191.33bn
- $44.33bn
Deals of the day-Mergers and acquisitions
Exact Sciences rises, Abbott falls on $23 billion buyout deal
Abbott’s colon-screening deal stinks financially
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade
Deals of the day-Mergers and acquisitions
Brief: Abbott -Deal Expected To Be Dilutive To Adjusted Earnings Per Share Through 2027- SEC Filing
Exact Sciences rises on $21 billion buyout deal with Abbott
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences (updated)
Brief: Abbott To Acquire Exact Sciences, A Leader In Large And Fast-Growing Cancer Screening And Precision Oncology Diagnostics Segments
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
Deals of the day-Mergers and acquisitions
Exact Sciences rise after report Abbott is weighing takeover of co
Abbott is weighing takeover of Exact Sciences, Bloomberg News reports (updated)
Abbott is weighing takeover of Exact Sciences, Bloomberg News reports
Brief: Abbott Weighs Takeover Of Cancer Test Maker Exact Sciences - Bloomberg News
Medtronic, Abbott fall after CDMO cites slow adoption of some heart and nerve devices
Boston Scientific lifts annual profit forecast on strong demand for heart devices (updated)
Boston Scientific lifts annual profit forecast on strong demand for heart devices
Walmart to be first US retailer to sell Abbott's continuous glucose monitor (updated)